Are pleural effusions a common complication in patients undergoing hemodialysis (HD) for end-stage renal disease (ESRD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pleural Effusions in Hemodialysis Patients

Yes, pleural effusions are a common complication in hemodialysis patients, occurring in approximately 20-25% of hospitalized ESRD patients undergoing chronic dialysis. 1, 2, 3

Epidemiology and Clinical Significance

  • Pleural effusions affect roughly 1 in 4 hospitalized hemodialysis patients, with prevalence estimates ranging from 20.2% to 24.7% across multiple studies. 1, 2, 3

  • This is not a benign finding—ESRD patients who develop pleural effusions have a dramatically worse prognosis, with 6-month and 1-year mortality rates of 31% and 46% respectively, which is three times higher than the general ESRD population. 4, 2

  • Most patients experience significant dyspnea and symptom burden requiring intervention. 4, 2

Common Etiologies in Hemodialysis Patients

Fluid overload is by far the most common cause, accounting for 61.5% of cases, followed by heart failure at 9.6%. 1, 3

Other important causes to consider include:

  • Uraemic pleuritis (16% of cases)—presents as exudative, often hemorrhagic effusion in underdialyzed patients. 1, 5

  • Hypoalbuminemia from nephrotic syndrome—causes decreased oncotic pressure leading to transudative effusions. 1, 2

  • Infection or malignancy—this population has significant immunosuppression risk. 1, 4

  • Vascular abnormalities from hemodialysis access complications—typically presents as unilateral transudative effusion. 1

  • Hemorrhagic effusions can occur due to antiplatelet therapy, heparin administration during dialysis, or uremic coagulopathy. 6, 7

Key Clinical Patterns

  • Bilateral effusions occur in approximately 69% of cases, but unilateral effusions are present in nearly half of patients (48%), warranting investigation for alternative diagnoses beyond simple volume overload. 4, 3

  • Both transudative (64.3%) and exudative (35.7%) effusions occur, so don't assume all effusions in dialysis patients are transudates from fluid overload. 3

  • Light's criteria has poor specificity (44%) in the dialysis population with high false-positive rates for exudates, so interpret cautiously. 4, 8

Critical Pitfall to Avoid

Do not assume all pleural effusions in hemodialysis patients are simply from volume overload. The European Respiratory Society emphasizes ruling out infection, malignancy, and other non-fluid overload etiologies before attributing effusions solely to hypervolemia, as this population carries significant risk for both pleural infection and malignancy. 4, 2, 8

When to Investigate Further

Obtain thoracentesis and consider CT chest when:

  • Unilateral effusion is present (suggests alternative diagnosis beyond simple fluid overload). 4, 3
  • Exudative characteristics are found on initial sampling. 4
  • Clinical suspicion exists for infection or malignancy (fever, weight loss, chest pain). 4, 8
  • Effusion persists despite 2-3 weeks of optimized dialysis with aggressive ultrafiltration. 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pleural Effusion in End-Stage Renal Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pleural effusion in long-term hemodialysis patients.

Transplantation proceedings, 2007

Guideline

Management of Pleural Effusion in ESRD Patients on Dialysis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Pleural Effusions in End-Stage Renal Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.